Substance Use Tools & Resources    

This Topic Brief discusses perinatal behavioral health conditions, which include mental health and substance use disorders during pregnancy and the postpartum period (up to 12 months after delivery).

This resource offers background information and tips for providers on how to use person-first language and on which terms to avoid using to reduce stigma and negative bias when discussing addiction or substance use disorder with pregnant women and mothers.

The following checklist intends to support health care teams in providing evidence-based recommendations for treating pregnant and postpartum patients with OUD. The checklist is divided into five sections, sequenced by timing of presentation to care.

These reports and detailed tables present estimates from the 2019 National Survey on Drug Use and Health (NSDUH), specifically pertaining to substance use among women.

This toolkit is a guide to help health care and social service organization leaders and providers improve care coordination for women with opioid use disorder in Health Resources and Services Administration-supported programs and other settings of care.

This brief describes the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model for pregnant and postpartum women with substance use disorders and how to implement and integrate SBIRT into care delivery.

This research report from NIDA discusses sex and gender influences in substance use, highlighting the unique needs of women when addressing substance use. disorder treatment

Addresses concerns about prescription drug abuse and maternal-fetal exposure to opioids.

Provides information for treating pregnant and parenting women with OUD, as well as their infants.

Discusses how prenatal opioid exposure affects the health and wellness of women and their newborns and identifies effective strategies to address barriers to care for women and newborns affected by perinatal substance use disorder and NAS.